Photodynamic therapies: Principles and present medical applications

Bio-Medical Materials and Engineering

Volumn 16, Issue 4 SUPPL., 2006, Pages

  Silva, João N ^a   Filipe, Paulo ^a   Morlière, Patrice ^b   Mazière, Jean Claude ^b   Freitas, João P ^c   Cirne De Castro, José L ^c   Santus, René ^c,d  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; PROTOPORPHYRIN; SKIN CANCERS; TETRAPYRROLE DERIVATIVES;

PHOTOSENSITIVITY; PHOTOSENSITIZERS; PORPHYRINS; PROTEINS; PULMONARY DISEASES; TUMORS;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; LOW DENSITY LIPOPROTEIN; PHOTOFRIN; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; TETRAPYRROLE DERIVATIVE;

ANGIOPLASTY; ESOPHAGUS TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGHT ABSORPTION; LUNG TUMOR; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRIORITY JOURNAL; RESTENOSIS; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SKIN TUMOR; TUMOR CELL CULTURE; TUMOR VASCULARIZATION;

AMINOLEVULINIC ACID; BOWEN'S DISEASE; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; HUMANS; LIGHT; LIPOPROTEINS, LDL; MALE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SKIN DISEASES; SKIN NEOPLASMS;

EID: 33745470572     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. A. Tanew, A. Guggenbichler, H. Honigsmann, J.M. Geiger and P. Fritsch, Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study, J. Am. Acad. Dermatol. 25 (1991), 682-684.
2. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst. 90 (1998), 889-905.
3. E. Kohen, R. Santus and J.G. Hirschberg, Photobiology, Academic Press, San Diego, 1995, pp. 23-95.
4. B.C. Wilson, W.P. Jeeves and D.M. Lowe, Post mortem measurements of the attenuation spectra of light in mammalian tissues, Photochem. Photobiol. 42 (1985), 153-162.
5. J.P. Reyftmann, P. Morliere, S. Goldstein, R. Santus, L. Dubertret and D. Lagrange, Interaction of human low density lipoproteins with porphyrins: a spectroscopic study, Photochem. Photobiol. 40 (1984), 721-729.
6. G. Jori, M. Beltramini, E. Reddie, B. Salvato, A. Pagnan, L. Ziron, L. Tomio and T. Tsanov, Evidence for the major role of plasma lipoproteins as haematoporphyrin carriers, Cancer Lett. 24 (1984), 291-297.
7. C. Candide, P. Morliere, J.-C. Maziere, S. Goldstein, R. Santus, L. Dubertret, J.P. Reyftmann and J. Polonovski, In vitro interaction of the photoactive anticancer porphyrin derivative Photofrin II with low density lipoprotein and its delivery to cultured human fibroblasts, FEBS Lett. 207 (1986), 133-138.
8. D. Kessel, Porphyrin lipoprotein association as a factor in porphyrin localization, Cancer Lett. 33, (1986), 183-188.
9. K. Berg, Mechanisms of cell damage in photodynamic therapy, in: The Fundamental Bases of Phototherapy, A. Young, H. Honigsmann and G. Jori, eds, OEMF, Milan, 1996, pp. 181-216.
10. M. Gèze, J.M. Gaullier, M. Bazin and R. Santus, Sub-cellular localization of second generation PDT photosensitizers studied by microspectrofluorometry, in: Analytical Use of Fluorescent Probes in Oncology, E. Kohen and J.G. Hirschberg, eds, Plenum Press, New York, 1996, pp. 113-121.
11. J.P. Reyftmann, E. Kohen, P. Morliere, R. Santus, C. Kohen, W.F. Mangel, L. Dubertret and J.G. Hirschberg, A microspectrofluorometric study of porphyrin-photosensitized single living cells. I. Membrane alterations, Photochem. Photobiol. 44 (1986), 461-470.
12. G. Ouédraogo and R.W. Redmond, Secondary reactive species extend the range of photosensitized effects in cells: DNA damage produced via initial membrane sensitization, Photochem. Photobiol. 77 (2003), 192-203.
13. M. Korbelik and G. Krosl, Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy, Photochem. Photobiol. 60 (1994), 497-502.
14. U. Schmidt-Erfurth and T. Hasan, Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration, Surv. Ophtalmol. 45 (2000), 195-214.
15. J.F. Savary, P.H. Monnier, C. Fontolliet, J. Mizeret, G. Wagnières, D. Braichotte and H. Van den Bergh, Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi and mouth with m-tetra(hydroxylphenyl)chlorin, Arch. Otolaryngol. Head Neck Surg. 123 (1997), 162-168.
16. 6 and diode laser for early superficial squamous cell carcinoma of the lung, Lung Cancer 42 (2003), 103-111.
17. B.F. Overholt, M. Panjepour and J.M. Haydeck, Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients, Gastrointest. Endosc. 49 (1999), 1-7.
18. J.C. Kennedy and R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B, Biol. 14 (1995), 275-292.
19. P. Morliere, E. Kohen, J.P. Reyftmann, R. Santus, C. Kohen, J.-C. Maziere, S. Goldstein, W.F. Mangel and L. Dubertret, Photosensitization by porphyrins delivered to L cells fibroblasts by human serum low density lipoproteins. A microspectrofluorometric study, Photochem. Photobiol. 46 (1987), 183-191.
20. J.M. Gaullier, K. Berg, Q. Peng, H. Anholt, P.K. Selbo, L.W. Ma and J. Moan, Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture, Cancer Res. 57 (1997), 1481-1486.
21. O.A. Gederaas, A. Holroyd, S.B. Brown et al., 5-Aminolevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line, Photochem. Photobiol. 73 (2001), 164-169.
22. C. Fritsch, B. Homey, W. Stahl, D. Vernon, J. Moan and K. Berg, Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester, Photochem. Photobiol. 68 (1998), 218-221.
23. E. Angell-Petersen, K.E. Giercksky and J. Moan, Protoporphyrin IX accumulation in basal cell carcinoma and normal skin after topical application of methyl aminolevulinate (M-ALA) [poster presentation], in: 30th Annual Meeting of the American Society for Photobiology, 2002 July 13-17, Quebec City.
24. D.M. Pariser, N.J. Lowe, D.M. Stewart, M.T. Jarratt, A.W. Lucky, R.J. Pariser and P.S. Yamauchi, Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial, J. Am. Acad. Dermatol. 48(Suppl. 2) (2003), 227-232.
25. L.E. Rhodes, M. de Rie, Y. Enstrom, R. Groves, T. Morken, V. Goulden, G.A. Wong, J.J. Grob, S. Varma and P. Wolf, Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial, Arch. Dermatol. 140 (2004), 17-23.
26. C.A. Morton, S.B. Brown, S. Collins, S. Ibbotson, H. Jenkinson, H. Kurwa, K. Langmack, K. McKenna, H. Moseley, A.D. Pearse, M. Stringer, D.K. Taylor, G. Wong and L.E. Rhodes, Guidelines for topical photodynamic therapy: report of workshop of the British Photodermatology Group, British J. Dermatol. 146 (2002), 552-567.
27. J. Silva, P. Filipe and J.L. Cirne de Castro, Topical photodynamic therapy with methyl aminolaevulinate for the treatment of cutaneous T cell lymphoma [oral communication], in: Annual Congress of the European Society for Photodynamic Therapy, 2005 March 4-5, Sirmione Italy.
28. Q. Peng, A.M. Soler, T. Warloe, J.M. Nesland and K.E. Giercksky, Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate, J. Photochem. Photobiol. B. Biol. 62 (2001), 140-145.